Poolbeg Pharma (LON:POLB) Stock Price Down 1.9%

Shares of Poolbeg Pharma PLC (LON:POLB) traded down 1.9% during mid-day trading on Wednesday . The company traded as low as GBX 12.32 ($0.16) and last traded at GBX 12.75 ($0.16). 2,396,098 shares changed hands during mid-day trading, an increase of 17% from the average session volume of 2,053,581 shares. The stock had previously closed at GBX 13 ($0.17).

Poolbeg Pharma Price Performance

The business’s 50 day simple moving average is GBX 12.55 and its 200-day simple moving average is GBX 10.50. The stock has a market capitalization of £63.75 million, a P/E ratio of -1,275.00 and a beta of 2.16.

About Poolbeg Pharma

Poolbeg Pharma plc operates as a biopharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in­licensed first­in­class broad spectrum RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis.